OSCR

PARP7 inhibition and a STING agonist potentiate radiation-induced immunogenicity in glioblastoma.

Overview

Authors: Luca Lippert1,2,3,4,5, Ava Kleinwächter1,2,4,5,6, Anna Ohradanova-Repic7, Filip Horvat1,2,4,5, Lisa-Marie Appel1,2,4,5, Lena Walch1,2,4,5, Niccolò Bragato1,2,3, Jakob Wimmer1,2,3, Hanna Wopfner1,2,3,4,5, Anna Röhrer1,2,3, Magdalena Engl1,2,4,5,6, Kapil Upadhyaya8, Joachim Widder1,2, Michael S Cohen8, Dea Slade1,2,3,4,5
  1. Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria
  2. Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
  3. MedAustron Ion Therapy Center, Wiener Neustadt, Austria
  4. Max Perutz Labs, Vienna Biocenter Campus (VBC), Vienna, Austria
  5. Medical University of Vienna, Center for Medical Biochemistry, Vienna, Austria
  6. Vienna Biocenter PhD Program, A Doctoral School of the University of Vienna and the Medical University of Vienna, Vienna, Austria
  7. Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute for Hygiene and Applied Immunology, Vienna, Austria
  8. Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA
Journal: Oncoimmunology, volume 15, issue 1, article 2656053
Dates: received 26 May 2025; accepted 1 April 2026; published online 14 April 2026; in print December 2026
Type: Research article · Language: English
License: CC BY-NC
Identifiers: DOI 10.1080/2162402x.2026.2656053 · PMID 41979168 · PMCID PMC13081750 · OpenAlex W7154201665
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), mouse (organism), other condition (population), cellular / molecular (subfield)
Methods: Connectivity, Statistics, Evoked potentials, fMRI & imaging
Keywords: Glioblastoma, radiation, PARP7, STING agonist, IFN-I response
MeSH: Brain Neoplasms*, Glioblastoma*, Membrane Proteins*, Poly(ADP-ribose) Polymerase Inhibitors*, Animals, Cell Line, Tumor, cGAS-STING Signaling Pathway, Humans, Interferon Type I, Mice, Neoplastic Stem Cells, Signal Transduction, STING Protein, Tumor Microenvironment (* major topic)
Topic: interferon and immune responses (Immunology, Immunology and Microbiology), according to OpenAlex
Funding: Austrian Science Fund FWF (P 34253)
Citations: cited by 2 papers (Europe PMC); 109 references in the paper

Abstract

Glioblastoma (GBM) is the most lethal form of brain cancer with an immunosuppressive tumor microenvironment (TME). Radio- and chemotherapy can modify the TME and elicit anti-tumor immunity through the STING and type I interferon (IFN-I) pathways. STING agonists or DNA damage response inhibitors can potentiate the effects of radiation by targeting the IFN-I pathway. Here, we examined the immunogenic response of GBM cells to hypofractionated or single-dose radiation combined with a STING agonist or inhibitors targeting immune signaling (PARP7), the DNA damage response, cell cycle checkpoints or autophagy. We found that hypofractionated radiation elicited a ferroptosis-dependent IFN-I response and that the PARP7 inhibitor KMR-206 and the STING agonist diABZI enhanced the effects of radiation by activating immune cells. In patient-derived GBM cancer stem cells with low STING levels, the PARP7 inhibitor was more effective at inducing immunogenic signaling compared to the STING agonist. Our results highlight the potential of PARP7 inhibitors as a new treatment to boost anti-tumor immunity in GBM, which may be more advantageous compared to STING agonists given that STING is often downregulated in GBM.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The RNA-seq data that support the findings of this study are openly available in Array Express at https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-14858?key=fe296ac5-b9e9-4e67-846c-1e9f756c30eb, accession number: E-MTAB-14858. The raw data files (uncropped western blots, western blot quantifications and data points for all replicates shown in the graphs) are provided in Supplementary Data 3 (for the main figures) and Supplementary Data 4 and 5 (for Supplementary figures). Any other information is available from the corresponding author upon request.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 15 authors, 5 keywords, 14 MeSH terms, 1 funder, 109 references.

Cite

This paper

Lippert, L., Kleinwächter, A., Ohradanova-Repic, A., Horvat, F., Appel, L.-M., Walch, L., Bragato, N., Wimmer, J., Wopfner, H., Röhrer, A., Engl, M., Upadhyaya, K., Widder, J., Cohen, M. S., & Slade, D. (2026). PARP7 inhibition and a STING agonist potentiate radiation-induced immunogenicity in glioblastoma. Oncoimmunology, 15(1), 2656053. https://doi.org/10.1080/2162402x.2026.2656053

BibTeX

@article{lippert2026parp7,
author = {Lippert, Luca and Kleinwächter, Ava and Ohradanova-Repic, Anna and Horvat, Filip and Appel, Lisa-Marie and Walch, Lena and Bragato, Niccolò and Wimmer, Jakob and Wopfner, Hanna and Röhrer, Anna and Engl, Magdalena and Upadhyaya, Kapil and Widder, Joachim and Cohen, Michael S and Slade, Dea},
title = {{PARP7 inhibition and a STING agonist potentiate radiation-induced immunogenicity in glioblastoma}},
journal = {Oncoimmunology},
year = {2026},
month = apr,
volume = {15},
number = {1},
pages = {2656053},
publisher = {Taylor \& Francis},
issn = {2162-4011},
doi = {10.1080/2162402x.2026.2656053},
url = {https://doi.org/10.1080/2162402x.2026.2656053},
pmid = {41979168},
pmcid = {PMC13081750}
}

RIS

TY - JOUR
AU - Lippert, Luca
AU - Kleinwächter, Ava
AU - Ohradanova-Repic, Anna
AU - Horvat, Filip
AU - Appel, Lisa-Marie
AU - Walch, Lena
AU - Bragato, Niccolò
AU - Wimmer, Jakob
AU - Wopfner, Hanna
AU - Röhrer, Anna
AU - Engl, Magdalena
AU - Upadhyaya, Kapil
AU - Widder, Joachim
AU - Cohen, Michael S
AU - Slade, Dea
TI - PARP7 inhibition and a STING agonist potentiate radiation-induced immunogenicity in glioblastoma
T2 - Oncoimmunology
J2 - Oncoimmunology
PY - 2026
DA - 2026/04/14
VL - 15
IS - 1
SP - 2656053
SN - 2162-4011
PB - Taylor & Francis
DO - 10.1080/2162402x.2026.2656053
UR - https://doi.org/10.1080/2162402x.2026.2656053
LA - en
ER -

CSL-JSON

{
"id": "10.1080/2162402x.2026.2656053",
"type": "article-journal",
"title": "PARP7 inhibition and a STING agonist potentiate radiation-induced immunogenicity in glioblastoma",
"container-title": "Oncoimmunology",
"author": [
{
"family": "Lippert",
"given": "Luca"
},
{
"family": "Kleinwächter",
"given": "Ava"
},
{
"family": "Ohradanova-Repic",
"given": "Anna"
},
{
"family": "Horvat",
"given": "Filip"
},
{
"family": "Appel",
"given": "Lisa-Marie"
},
{
"family": "Walch",
"given": "Lena"
},
{
"family": "Bragato",
"given": "Niccolò"
},
{
"family": "Wimmer",
"given": "Jakob"
},
{
"family": "Wopfner",
"given": "Hanna"
},
{
"family": "Röhrer",
"given": "Anna"
},
{
"family": "Engl",
"given": "Magdalena"
},
{
"family": "Upadhyaya",
"given": "Kapil"
},
{
"family": "Widder",
"given": "Joachim"
},
{
"family": "Cohen",
"given": "Michael S"
},
{
"family": "Slade",
"given": "Dea"
}
],
"container-title-short": "Oncoimmunology",
"volume": "15",
"issue": "1",
"page": "2656053",
"DOI": "10.1080/2162402x.2026.2656053",
"PMID": "41979168",
"PMCID": "PMC13081750",
"ISSN": "2162-4011",
"publisher": "Taylor & Francis",
"URL": "https://doi.org/10.1080/2162402x.2026.2656053",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
14
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1007/s00401-024-02688-z [code]
Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia.
Journal: Acta neuropathologica
In common: other condition, mouse, cellular / molecular, 5 references
[2] doi:10.1038/s41467-023-36878-2 [code]
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade.
Journal: Nature communications
In common: other condition, mouse, cellular / molecular, 3 references
[3] doi:10.1038/s41467-023-37328-9
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma.
Journal: Nature communications
In common: other condition, mouse, cellular / molecular, 3 references
[4] doi:10.1038/s42003-022-03654-9
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression.
Journal: Communications biology
In common: other condition, mouse, cellular / molecular, 6 references
[5] doi:10.1186/s13059-026-03946-x
MER57E3 transposable elements regulate gene expression in a human cell model of neural development.
Journal: Genome biology
In common: 6 references
[6] doi:10.7554/elife.81943
Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice.
Journal: eLife
In common: other condition, mouse, cellular / molecular, 3 references
[7] doi:10.1073/pnas.2111003119
STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: other condition, mouse, cellular / molecular, 4 references
[8] doi:10.1242/dmm.049995
A zebrafish model of combined saposin deficiency identifies acid sphingomyelinase as a potential therapeutic target.
Journal: Disease models & mechanisms
In common: other condition, cellular / molecular, 6 references
[9] doi:10.1038/s44319-024-00123-8
Mcph1, mutated in primary microcephaly, is also crucial for erythropoiesis.
Journal: EMBO reports
In common: mouse, 6 references
[10] doi:10.1016/j.molcel.2025.07.005 [code]
Chromatin-dependent motif syntax defines differentiation trajectories.
Journal: Molecular cell
In common: mouse, cellular / molecular, 5 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.